Advisor Group Holdings, Inc. Edwards Lifesciences Corp Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 64,380 shares of EW stock, worth $4.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

64,380

Previous 63,113 2.01%

Holding current value

$4.89 Million

Previous $4.16 Million 14.46%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$64.54 - $75.92 $81,772 - $96,190	1,267 Added 2.01%	64,380 $4.77 Million
Q3 2024 Nov 13, 2024	SELL	$59.7 - $93.78 $1.57 Million - $2.47 Million	-26,351 Reduced 29.45%	63,113 $4.16 Million
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $1.47 Million - $1.64 Million	-17,442 Reduced 16.32%	89,464 $8.26 Million
Q1 2024 May 10, 2024	SELL	$72.54 - $95.56 $7.19 Million - $9.47 Million	-99,052 Reduced 48.09%	106,906 $10.2 Million
Q4 2023 Feb 12, 2024	SELL	$61.71 - $77.76 $8.89 Million - $11.2 Million	-143,984 Reduced 41.15%	205,958 $15.7 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $6.16 Million - $8.3 Million	88,933 Added 34.07%	349,942 $24.2 Million
Q2 2023 Aug 21, 2023	SELL	$81.41 - $94.33 $81.9 Million - $94.9 Million	-1,006,285 Reduced 79.4%	261,009 $24.6 Million
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $82 Million - $95.1 Million	1,007,686 Added 388.16%	1,267,294 $120 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $1.23 Million - $1.4 Million	16,557 Added 6.81%	259,608 $21.5 Million
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $2.26 Million - $2.89 Million	33,037 Added 15.73%	243,051 $18.1 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $1.82 Million - $2.38 Million	-22,155 Reduced 9.54%	210,014 $17.4 Million
Q2 2022 Aug 10, 2022	BUY	$86.5 - $128.27 $1.7 Million - $2.52 Million	19,641 Added 9.24%	232,169 $22.1 Million
Q1 2022 May 04, 2022	BUY	$101.96 - $128.34 $2.23 Million - $2.81 Million	21,904 Added 11.49%	212,528 $27.5 Million
Q3 2021 Nov 05, 2021	BUY	$102.91 - $122.75 $1.15 Million - $1.37 Million	11,138 Added 6.21%	190,624 $21.6 Million
Q2 2021 Aug 02, 2021	BUY	$83.84 - $104.76 $545,714 - $681,882	6,509 Added 3.76%	179,486 $18.6 Million
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $826,926 - $952,941	-10,510 Reduced 5.73%	172,977 $14.5 Million
Q4 2020 Feb 10, 2021	SELL	$71.69 - $91.23 $1.31 Million - $1.67 Million	-18,251 Reduced 9.05%	183,487 $16.7 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $649,928 - $845,807	9,673 Added 5.04%	201,738 $16 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $7.45 Million - $9.96 Million	129,428 Added 206.63%	192,065 $13.3 Million
Q1 2020 May 18, 2020	BUY	$52.41 - $81.0 $3.28 Million - $5.07 Million	62,637 New	62,637 $11.1 Million

Others Institutions Holding EW

# of Institutions

1,373

Shares Held

475M

Call Options Held

9.51M

Put Options Held

3.93M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $47B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Edwards Lifesciences Corp Transaction History